Video -

Haemophilia therapy from largest multi-year donation now available to patients in developing world

Biogen, Sobi and the World Federation of Hemophilia collaboration to enable a sustained humanitarian supply of haemophilia treatment with the potential to change treatment paradigm in developing countries.
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .mp4
  • Length: 2:25
Download

Topics

  • Medical research

Categories

  • sobi
  • biogen
  • haemophilia
  • wfh
  • humanitarian aid donation

Contacts

Charlotte af Klercker

Press contact Senior Communications Manager 0707-297327

Related content

Haemophilia therapy from largest multi-year donation now available to patients in developing world

World Federation of Hemophilia announces expansion of humanitarian aid programme. Biogen, Sobi and the World Federation of Hemophilia collaboration to enable a sustained humanitarian supply of haemophilia treatment with the potential to change treatment paradigm in developing countries.

Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment of haemophilia in developing world

Biogen Idec and Sobi today announced their intent to produce one billion international units of clotting factor therapy for humanitarian aid programs in the developing world at the World Federation of Hemophilia 2014 World Congress.